These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 6163491
21. Cardiac arrhythmias during experimental induction and management of myocardial infarction in the dog. Beyer M, Hoffer H, Eggeling T, Mierdl S, Beyer U, Hannekum A. J Exp Anim Sci; 1992 Aug; 35(2):89-95. PubMed ID: 1390961 [Abstract] [Full Text] [Related]
22. Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarction. Lynch JJ, Wallace AA, Stump GL, Stupienski RF, Kothstein T, Gehret JR. J Pharmacol Exp Ther; 1996 May; 277(2):671-8. PubMed ID: 8627544 [Abstract] [Full Text] [Related]
23. The persistent sodium current blocker riluzole is antiarrhythmic and anti-ischaemic in a pig model of acute myocardial infarction. Weiss SM, Saint DA. PLoS One; 2010 Nov 24; 5(11):e14103. PubMed ID: 21124787 [Abstract] [Full Text] [Related]
24. [Prevention and treatment of drug-induced arrhythmia in acute myocardial infarct]. Steffen V, Fiehring H. Z Gesamte Inn Med; 1972 Oct 15; 27(20):875-81. PubMed ID: 4405247 [No Abstract] [Full Text] [Related]
25. Experimental studies on the antiarrhythmic action of a lidocaine analog. Okuma K, Sugiyama S, Wada M, Sugenoya J, Niimi N. Cardiology; 1976 Oct 15; 61(4):289-97. PubMed ID: 65226 [Abstract] [Full Text] [Related]
26. Re-entrant ventricular arrhythmias in the late myocardial infarction period. 4. Mechanism of action of lidocaine. El-Sherif N, Scherlag BJ, Lazzara R, Hope RR. Circulation; 1977 Sep 15; 56(3):395-402. PubMed ID: 69503 [Abstract] [Full Text] [Related]
27. Combination Formulation of Tetrodotoxin and Lidocaine as a Potential Therapy for Severe Arrhythmias. Hong B, He J, Le Q, Bai K, Chen Y, Huang W. Mar Drugs; 2019 Dec 05; 17(12):. PubMed ID: 31817438 [Abstract] [Full Text] [Related]
28. [Comparison of aprindine (AC 1802) and lidocaine by intravenous route during the acute phase of myocardial infarct]. Depaepe A, Bohyn P, De Maertelaere M, Dernier J, Cloetens W, De Mey D. Acta Cardiol; 1974 Dec 05; Suppl 18():423-32. PubMed ID: 4138738 [No Abstract] [Full Text] [Related]
29. Rotigaptide (ZP123) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. Hennan JK, Swillo RE, Morgan GA, Keith JC, Schaub RG, Smith RP, Feldman HS, Haugan K, Kantrowitz J, Wang PJ, Abu-Qare A, Butera J, Larsen BD, Crandall DL. J Pharmacol Exp Ther; 2006 Apr 05; 317(1):236-43. PubMed ID: 16344331 [Abstract] [Full Text] [Related]
30. Occurrence of a tetrodotoxin-sensitive calcium current in rat ventricular myocytes after long-term myocardial infarction. Alvarez JL, Salinas-Stefanon E, Orta G, Ferrer T, Talavera K, Galán L, Vassort G. Cardiovasc Res; 2004 Sep 01; 63(4):653-61. PubMed ID: 15306221 [Abstract] [Full Text] [Related]
31. Facilitation of reentry by lidocaine in canine myocardial infarction. Fazekas T, Scherlag BJ, Mabo P, Patterson E, Lazzara R. Acta Physiol Hung; 1994 Sep 01; 82(3):201-13. PubMed ID: 7717083 [Abstract] [Full Text] [Related]
33. Lorcainide in the prophylaxis of ventricular arrhythmias in acute myocardial infarction. Leinonen H, Heikkilä J, Sundberg S, Gordin A. Ann Clin Res; 1984 Sep 01; 16(1):18-22. PubMed ID: 6378045 [Abstract] [Full Text] [Related]
34. Differential contribution of sodium channel subtypes to action potential generation in unmyelinated human C-type nerve fibers. Lang PM, Hilmer VB, Grafe P. Anesthesiology; 2007 Sep 01; 107(3):495-501. PubMed ID: 17721253 [Abstract] [Full Text] [Related]
35. Electrophysiological evidence that local anesthetics and antiarrhythmic drugs bind to a specific receptor site in cardiac sodium channels: displacement of bupivacaine by lidocaine. Clarkson CW, Hondeghem LM. Proc West Pharmacol Soc; 1984 Sep 01; 27():23-5. PubMed ID: 6093130 [No Abstract] [Full Text] [Related]
36. The role of late I and antiarrhythmic drugs in EAD formation and termination in Purkinje fibers. Fedida D, Orth PM, Hesketh JC, Ezrin AM. J Cardiovasc Electrophysiol; 2006 May 01; 17 Suppl 1():S71-S78. PubMed ID: 16686685 [Abstract] [Full Text] [Related]
37. Dose-related shortening of ventricular tachycardia cycle length after administration of the KATP channel opener bimakalim in a 4-day-old chronic infarct anesthetized pig model. Aidonidis I, Poyatzi A, Stamatiou G, Lymberi M, Stamatoyannis N, Molyvdas PA. J Cardiovasc Pharmacol Ther; 2009 Sep 01; 14(3):222-30. PubMed ID: 19587223 [Abstract] [Full Text] [Related]
38. Lidocaine has a narrow antiarrhythmic dose range against ventricular arrhythmias induced by programmed electrical stimulation in conscious postinfarction dogs. Krejcy K, Krumpl G, Todt H, Raberger G. Naunyn Schmiedebergs Arch Pharmacol; 1992 Aug 01; 346(2):213-8. PubMed ID: 1448183 [Abstract] [Full Text] [Related]
39. [Effect of lidocaine and pyromecaine on the size of an experimental myocardial infarct]. Goldshteĭne GKh, Tsorin IB, Chichkanov GG. Biull Eksp Biol Med; 1986 Feb 01; 101(2):177-9. PubMed ID: 3947734 [Abstract] [Full Text] [Related]
40. Canine-effective plasma concentrations of antiarrhythmic drugs on the two-stage coronary ligation arrhythmia. Hashimoto K, Satoh H, Shibuya T, Imai S. J Pharmacol Exp Ther; 1982 Dec 01; 223(3):801-10. PubMed ID: 7143241 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]